Day: November 6, 2023

Coherus BioSciences Reports Third Quarter 2023 Financial Results and Business Highlights

Written by Customer Service on November 6, 2023. Posted in Earnings Releases And Operating Results.

– Net revenue rose 27% from prior quarter to $74.6 million –– CIMERLI® net sales increased 50% to $40 million compared to prior quarter –– LOQTORZI™ now approved with launch planned for the first quarter of 2024 –– Conference call today at 5:00 p.m. Eastern Time – REDWOOD CITY, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS), today reported financial results for the quarter ended September 30, 2023, and recent business highlights: RECENT BUSINESS HIGHLIGHTS CIMERLI®CIMERLI® (ranibizumab-eqrn) net product sales increased in the third quarter 2023 to $40.0 million compared to $26.7 million in the second quarter. CIMERLI® sales have exceeded 100,000 doses since commercial launch on October 3, 2022, and CIMERLI® held a 29% share of the overall ranibizumab market in the third quarter...

Consolidated Water Group Acquires Ramey Environmental Compliance, Broadening Presence in Water-Stressed Western U.S.

Written by Customer Service on November 6, 2023. Posted in Mergers And Acquisitions.

$4.2 Million All-Cash Transaction Brings Strong Water Services Expertise, and Exceptional Opportunities to Synergistically Expand and Grow the Business GEORGE TOWN, Cayman Islands and FOUNTAIN VALLEY, Calif. and DENVER, Nov. 06, 2023 (GLOBE NEWSWIRE) — Consolidated Water Co. Ltd. (NASDAQ Global Select Market: CWCO), a leading developer and operator of advanced water supply and treatment plants, announced that its wholly-owned subsidiary, PERC Water Corporation (PERC), has acquired a 100% ownership interest in Ramey Environmental Compliance (REC) for a total consideration of $4.2 million in cash. Founded in 1997 by Wayne and Linda Ramey, and headquartered in Frederick, Colorado, near Denver, REC operates and maintains water and wastewater treatment facilities and provides technical services throughout the Rocky Mountains and Eastern...

thredUP Announces Third Quarter 2023 Results

Written by Customer Service on November 6, 2023. Posted in Earnings Releases And Operating Results.

Quarterly revenue of $82.0 million, representing an increase of 21% year-over-year. U.S. business reached quarterly adjusted EBITDA breakeven for first time in company’s history. Third quarter gross margin of 69.0% and an increase in gross profit of 27% year-over-year. Record Active Buyers of 1.8 million and Orders of 1.8 million in Q3 2023, representing an increase of 4% and an increase of 11%, respectively, year-over-year. Continue to grow its Resale-as-a-Service (RaaS) client roster, launching new programs with Beyond Yoga, Smartwool, and Journeys. Recognized as one of TIME 100’s Most Influential Companies of 2023 and Digiday’s WorkLife 50 Awards.OAKLAND, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) — ThredUp Inc. (Nasdaq: TDUP, LTSE: TDUP), one of the largest online resale platforms for apparel, shoes, and accessories,...

Superior Group of Companies Reports Third Quarter 2023 Results

Written by Customer Service on November 6, 2023. Posted in Earnings Releases And Operating Results.

– Total Net Sales of $136.1 million versus $138.7 million in Prior Year Third Quarter –– Net Income of $3.1 million versus net loss of ($12.7) million in Prior Year Third Quarter –– Adjusted EBITDA of $9.3 million versus $9.7 million in Prior Year Third Quarter –– Board of Directors Approves $0.14 Per Share Quarterly Dividend –– Provides Updated Full-Year Outlook – ST. PETERSBURG, Fla., Nov. 06, 2023 (GLOBE NEWSWIRE) — Superior Group of Companies, Inc. (NASDAQ: SGC) (the “Company”), today announced its third quarter 2023 results. Third Quarter Results For the third quarter ended September 30, 2023, net sales decreased 1.9% to $136.1 million, compared to third quarter 2022 net sales of $138.7 million. Pretax income was $3.3 million compared to a pretax loss of ($17.0) million in the third quarter of 2022. Net income was $3.1 million...

Alto Ingredients, Inc. Reports Third Quarter 2023 Results

Written by Customer Service on November 6, 2023. Posted in Earnings Releases And Operating Results.

PEKIN, Ill., Nov. 06, 2023 (GLOBE NEWSWIRE) — Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols and essential ingredients, reported its financial results for the quarter ended September 30, 2023. “Our transition to provide high margin, differentiated specialty alcohols and essential ingredients in consumer, pharmaceutical, food, beverage and industrial products has greatly improved our financial profile over the past three years,” said Bryon McGregor, President and CEO of Alto Ingredients. “We continue to make good progress, yet we remain subject to operational and commodity market challenges. Our third quarter results reflect the contribution from stronger ethanol crush margins partially offset by the impact of unusually high unscheduled downtime that lowered our anticipated production...

Revolution Medicines Reports Third Quarter 2023 Financial Results and Update on Corporate Progress

Written by Customer Service on November 6, 2023. Posted in Earnings Releases And Operating Results.

Promising clinical data for RMC-6236, a RASMULTI(ON) Inhibitor, and RMC-6291, a RASG12C(ON) Inhibitor, presented at AACR-NCI-EORTC (“Triple”) and ESMO Meetings Acquisition of EQRx, Inc. expected to close later this month Revolution Medicines to hold webcast today at 4:30 p.m. Eastern Time REDWOOD CITY, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today announced its financial results for the quarter ended September 30, 2023, and provided an update on corporate progress. Recent HighlightsRMC-6236: Revolution Medicines presented promising anti-tumor activity data for RMC-6236, a RASMULTI(ON) Inhibitor, in patients with non-small cell lung cancer (NSCLC) or pancreatic ductal adenocarcinoma (PDAC) harboring...

Inventiva announces a late breaker abstract and two additional abstracts on its lead compound, lanifibranor, at the AASLD The Liver Meeting® 2023

Written by Customer Service on November 6, 2023. Posted in Public Companies.

The phase II study led by Dr. Kenneth Cusi evaluating lanifibranor in patients with T2D and MASLD was selected as late breaker. Two additional scientific abstracts from the NATIVE Phase IIb clinical trial evaluating lanifibranor for the treatment of patients with NASH have been selected for presentation. The two abstracts show:the correlation between the increase of adiponectin under lanifibranor and the improvement of histological and serum markers of NASH severity both in terms of activity and fibrosis. the improvement of liver histology and markers of cardiometabolic health in patients with NASH treated with lanifibranor, independent of PNPLA3 genotype.Daix (France), Long Island City (New York, United States), November 6, 2023 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company...

TSS, INC. TO REPORT THIRD QUARTER 2023 RESULTS ON MONDAY, NOVEMBER 13th, 2023

Written by Customer Service on November 6, 2023. Posted in Public Companies.

ROUND ROCK, Texas, Nov. 06, 2023 (GLOBE NEWSWIRE) — TSS, Inc. (Other OTC: TSSI), a data center and mission critical facilities and technology services company, will report financial results for its third quarter 2023 on Monday November 13th, 2023. The Company will conduct a conference call at 4.30 p.m. eastern time that day. To participate on the conference call, please dial 1-888-596-4144 toll free from the U.S., or 1-646-968-2525 for international callers. The event ID number is 3667493. Investors may also access a live audio web cast of this conference call under the “events” tab on the investor relations section of the Company’s website at https://tss-inc.ir.rdgfilings.com . An audio replay of the conference call will be available approximately four hours after the conclusion of the call and will be made available until...

TRULEUM EXPANDS HOLDINGS AT LOGAN PROJECT BY 400 ACRES INCREASING BEHIND PIPE RESERVES POTENTIAL

Written by Customer Service on November 6, 2023. Posted in Public Companies.

GOLDEN, Colo., Nov. 06, 2023 (GLOBE NEWSWIRE) — Truleum, Inc. (OTC.PK – TRLM) (“Truleum”) announced today that it has acquired quitclaim title to various tracts of the Logan Project covering approximately 400 additional acres. Ownership of the additional acres has now been clarified adding the approximate 400 acres covering nine (9) well bores owned and operated by Truleum. The company’s acreage held in the Project increased from 1380 to 1620 net acres. The new acreage adds behind-pipe potential in some of the nine affected wellbores and adds full interest in undrilled locations that Truleum can now access with clear title. The Company’s current reserve report dated October 16, 2023 was prepared by an independent petroleum engineering firm (“Liquid Gold Technologies”) prior to the acquisition of the additional acres. It is available...

Calian Announces President, IT and Cyber Solutions

Written by Customer Service on November 6, 2023. Posted in Public Companies.

OTTAWA, Nov. 06, 2023 (GLOBE NEWSWIRE) — Calian Group Ltd. (TSX: CGY), a diverse products and services company providing innovative healthcare, communications, learning and cybersecurity solutions is proud to announce the appointment of Michael Tremblay as President, IT and Cyber Solutions (ITCS). Mike joined Invest Ottawa & Bayview Yards as President and CEO in March of 2017. Recently, Mike was appointed a World Economic Forum Fellow as part of the Centre for Urban Transformation and Invest Ottawa’s leadership work at AREA X.O, Canada’s mobility Futureplex of innovation and collaboration. With 38 years of sales, marketing, operations, general management experience, coupled with considerable knowledge of public sector clients, Mike has held senior executive positions with Microsoft, SAP, Fujitsu Consulting, JDS Uniphase, EDS...

Day: November 6, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals